Illumina, Inc. (ILMN)
USD 77.85
(2.1%)
USD 77.85
(2.1%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 4.5 Billion USD | -1.75% |
| 2022 | 4.58 Billion USD | 1.28% |
| 2021 | 4.52 Billion USD | 39.73% |
| 2020 | 3.23 Billion USD | -8.58% |
| 2019 | 3.54 Billion USD | 6.3% |
| 2018 | 3.33 Billion USD | 21.11% |
| 2017 | 2.75 Billion USD | 14.74% |
| 2016 | 2.39 Billion USD | 8.05% |
| 2015 | 2.21 Billion USD | 19.25% |
| 2014 | 1.86 Billion USD | 30.97% |
| 2013 | 1.42 Billion USD | 23.74% |
| 2012 | 1.14 Billion USD | 8.81% |
| 2011 | 1.05 Billion USD | 16.93% |
| 2010 | 902.74 Million USD | 35.48% |
| 2009 | 666.32 Million USD | 16.24% |
| 2008 | 573.22 Million USD | 56.28% |
| 2007 | 366.79 Million USD | 98.71% |
| 2006 | 184.58 Million USD | 151.13% |
| 2005 | 73.5 Million USD | 45.31% |
| 2004 | 50.58 Million USD | 80.43% |
| 2003 | 28.03 Million USD | 179.23% |
| 2002 | 10.04 Million USD | 303.86% |
| 2001 | 2.48 Million USD | 89.9% |
| 2000 | 1.3 Million USD | 176.17% |
| 1999 | 474.02 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 1.08 Billion USD | -2.88% |
| 2024 Q1 | 1.07 Billion USD | -4.1% |
| 2024 Q2 | 1.11 Billion USD | 3.35% |
| 2023 Q2 | 1.17 Billion USD | 8.19% |
| 2023 Q1 | 1.08 Billion USD | 0.37% |
| 2023 FY | 4.5 Billion USD | -1.75% |
| 2023 Q4 | 1.12 Billion USD | 0.27% |
| 2023 Q3 | 1.11 Billion USD | -4.85% |
| 2022 FY | 4.58 Billion USD | 1.28% |
| 2022 Q4 | 1.08 Billion USD | -2.87% |
| 2022 Q3 | 1.11 Billion USD | -4.04% |
| 2022 Q2 | 1.16 Billion USD | -4.99% |
| 2022 Q1 | 1.22 Billion USD | 2.09% |
| 2021 Q1 | 1.09 Billion USD | 14.69% |
| 2021 Q2 | 1.12 Billion USD | 3.02% |
| 2021 Q4 | 1.19 Billion USD | 8.12% |
| 2021 Q3 | 1.1 Billion USD | -1.6% |
| 2021 FY | 4.52 Billion USD | 39.73% |
| 2020 Q3 | 794 Million USD | 25.43% |
| 2020 Q4 | 953 Million USD | 20.03% |
| 2020 FY | 3.23 Billion USD | -8.58% |
| 2020 Q1 | 859 Million USD | -9.86% |
| 2020 Q2 | 633 Million USD | -26.31% |
| 2019 Q4 | 953 Million USD | 5.07% |
| 2019 FY | 3.54 Billion USD | 6.3% |
| 2019 Q1 | 846 Million USD | -2.42% |
| 2019 Q2 | 838 Million USD | -0.95% |
| 2019 Q3 | 907 Million USD | 8.23% |
| 2018 FY | 3.33 Billion USD | 21.11% |
| 2018 Q1 | 782 Million USD | 0.51% |
| 2018 Q2 | 830 Million USD | 6.14% |
| 2018 Q3 | 853 Million USD | 2.77% |
| 2018 Q4 | 867 Million USD | 1.64% |
| 2017 Q1 | 598 Million USD | -3.45% |
| 2017 FY | 2.75 Billion USD | 14.74% |
| 2017 Q4 | 778 Million USD | 8.96% |
| 2017 Q3 | 714 Million USD | 7.85% |
| 2017 Q2 | 662 Million USD | 10.7% |
| 2016 FY | 2.39 Billion USD | 8.05% |
| 2016 Q4 | 619.34 Million USD | 2.01% |
| 2016 Q1 | 571.76 Million USD | -3.34% |
| 2016 Q3 | 607.13 Million USD | 1.17% |
| 2016 Q2 | 600.12 Million USD | 4.96% |
| 2015 Q1 | 538.56 Million USD | 5.11% |
| 2015 Q4 | 591.54 Million USD | 7.5% |
| 2015 Q2 | 539.37 Million USD | 0.15% |
| 2015 Q3 | 550.27 Million USD | 2.02% |
| 2015 FY | 2.21 Billion USD | 19.25% |
| 2014 Q4 | 512.37 Million USD | 6.61% |
| 2014 Q3 | 480.63 Million USD | 7.39% |
| 2014 Q2 | 447.56 Million USD | 6.37% |
| 2014 Q1 | 420.78 Million USD | 8.64% |
| 2014 FY | 1.86 Billion USD | 30.97% |
| 2013 FY | 1.42 Billion USD | 23.74% |
| 2013 Q4 | 387.32 Million USD | 8.56% |
| 2013 Q3 | 356.8 Million USD | 3.09% |
| 2013 Q2 | 346.09 Million USD | 4.57% |
| 2013 Q1 | 330.95 Million USD | 7.01% |
| 2012 Q4 | 309.26 Million USD | 8.18% |
| 2012 Q1 | 272.77 Million USD | 9.08% |
| 2012 Q3 | 285.87 Million USD | 1.88% |
| 2012 FY | 1.14 Billion USD | 8.81% |
| 2012 Q2 | 280.6 Million USD | 2.87% |
| 2011 Q2 | 287.45 Million USD | 1.75% |
| 2011 Q1 | 282.51 Million USD | 8.12% |
| 2011 FY | 1.05 Billion USD | 16.93% |
| 2011 Q4 | 250.07 Million USD | 6.19% |
| 2011 Q3 | 235.49 Million USD | -18.07% |
| 2010 FY | 902.74 Million USD | 35.48% |
| 2010 Q2 | 212 Million USD | 10.34% |
| 2010 Q3 | 237.3 Million USD | 11.94% |
| 2010 Q1 | 192.13 Million USD | 6.41% |
| 2010 Q4 | 261.29 Million USD | 10.11% |
| 2009 FY | 666.32 Million USD | 16.24% |
| 2009 Q1 | 165.75 Million USD | 3.0% |
| 2009 Q2 | 161.64 Million USD | -2.48% |
| 2009 Q4 | 180.56 Million USD | 14.02% |
| 2009 Q3 | 158.36 Million USD | -2.03% |
| 2008 FY | 573.22 Million USD | 56.28% |
| 2008 Q4 | 160.92 Million USD | 7.1% |
| 2008 Q3 | 150.26 Million USD | 7.19% |
| 2008 Q2 | 140.17 Million USD | 15.03% |
| 2008 Q1 | 121.86 Million USD | 8.22% |
| 2007 Q2 | 84.53 Million USD | 17.17% |
| 2007 Q1 | 72.15 Million USD | 19.38% |
| 2007 FY | 366.79 Million USD | 98.71% |
| 2007 Q4 | 112.6 Million USD | 15.48% |
| 2007 Q3 | 97.51 Million USD | 15.35% |
| 2006 Q4 | 60.43 Million USD | 13.02% |
| 2006 FY | 184.58 Million USD | 151.13% |
| 2006 Q1 | 29.1 Million USD | 26.46% |
| 2006 Q2 | 41.57 Million USD | 42.87% |
| 2006 Q3 | 53.47 Million USD | 28.61% |
| 2005 FY | 73.5 Million USD | 45.31% |
| 2005 Q2 | 15.82 Million USD | 4.46% |
| 2005 Q3 | 19.51 Million USD | 23.33% |
| 2005 Q4 | 23.01 Million USD | 17.92% |
| 2005 Q1 | 15.14 Million USD | 2.47% |
| 2004 Q2 | 11.48 Million USD | 6.32% |
| 2004 Q4 | 14.78 Million USD | 9.41% |
| 2004 Q3 | 13.51 Million USD | 17.64% |
| 2004 Q1 | 10.8 Million USD | 0.58% |
| 2004 FY | 50.58 Million USD | 80.43% |
| 2003 Q2 | 4.76 Million USD | 11.53% |
| 2003 Q3 | 8.24 Million USD | 72.97% |
| 2003 Q4 | 10.74 Million USD | 30.21% |
| 2003 Q1 | 4.27 Million USD | 10.04% |
| 2003 FY | 28.03 Million USD | 179.23% |
| 2002 Q2 | 1.9 Million USD | 49.72% |
| 2002 Q4 | 3.88 Million USD | 30.18% |
| 2002 Q3 | 2.98 Million USD | 57.11% |
| 2002 Q1 | 1.26 Million USD | 66.73% |
| 2002 FY | 10.04 Million USD | 303.86% |
| 2001 FY | 2.48 Million USD | 89.9% |
| 2001 Q3 | 691.35 Thousand USD | 47.15% |
| 2001 Q2 | 469.84 Thousand USD | -16.65% |
| 2001 Q1 | 563.69 Thousand USD | 16.31% |
| 2001 Q4 | 761.11 Thousand USD | 10.09% |
| 2000 Q3 | 662.58 Thousand USD | 742.43% |
| 2000 Q4 | 484.66 Thousand USD | -26.85% |
| 2000 Q1 | 83.2 Thousand USD | 0.0% |
| 2000 FY | 1.3 Million USD | 176.17% |
| 2000 Q2 | 78.65 Thousand USD | -5.47% |
| 1999 FY | 474.02 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 31.24 Million USD | -14313.261% |
| Applied DNA Sciences, Inc. | 13.36 Million USD | -33593.804% |
| Aspira Women's Health Inc. | 9.15 Million USD | -49102.534% |
| Biodesix, Inc. | 49.08 Million USD | -9075.545% |
| BioNexus Gene Lab Corp. | 9.77 Million USD | -45996.504% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -177748.047% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -177748.047% |
| Bionano Genomics, Inc. | 36.11 Million USD | -12370.927% |
| CareDx, Inc | 280.32 Million USD | -1506.712% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Castle Biosciences, Inc. | 219.78 Million USD | -1949.247% |
| DarioHealth Corp. | 20.35 Million USD | -22030.503% |
| Exact Sciences Corporation | 2.49 Billion USD | -80.177% |
| Fulgent Genetics, Inc. | 289.21 Million USD | -1457.33% |
| Guardant Health, Inc. | 563.94 Million USD | -698.655% |
| ICON Public Limited Company | 8.12 Billion USD | 44.533% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | -23.028% |
| Intelligent Bio Solutions Inc. | 3.11 Million USD | -144640.263% |
| iSpecimen Inc. | 9.92 Million USD | -45265.799% |
| Standard BioTools Inc. | 106.34 Million USD | -4135.471% |
| MDxHealth SA | 70.19 Million USD | -6316.594% |
| 23andMe Holding Co. | 219.63 Million USD | -1950.647% |
| Medpace Holdings, Inc. | 1.88 Billion USD | -138.832% |
| Myriad Genetics, Inc. | 678.4 Million USD | -563.915% |
| Mainz Biomed B.V. | 895.47 Thousand USD | -502871.036% |
| ENDRA Life Sciences Inc. | - USD | -Infinity% |
| NeoGenomics, Inc. | 591.64 Million USD | -661.27% |
| Neogen Corporation | 924.22 Million USD | -387.329% |
| Inotiv, Inc. | 572.42 Million USD | -686.828% |
| Natera, Inc. | 1.08 Billion USD | -316.047% |
| OpGen, Inc. | 3.41 Million USD | -131660.631% |
| OPKO Health, Inc. | 863.49 Million USD | -421.601% |
| Psychemedics Corporation | 22.09 Million USD | -20281.935% |
| Prenetics Global Limited | 21.74 Million USD | -20615.022% |
| Prenetics Global Limited | 21.74 Million USD | -20615.022% |
| Precipio, Inc. | 15.19 Million USD | -29537.428% |
| Personalis, Inc. | 73.48 Million USD | -6029.476% |
| RadNet, Inc. | 1.61 Billion USD | -178.604% |
| Sera Prognostics, Inc. | 306 Thousand USD | -1471795.425% |
| Sotera Health Company | 1.04 Billion USD | -329.243% |
| Neuronetics, Inc. | 71.34 Million USD | -6212.721% |
| Star Equity Holdings, Inc. | 45.78 Million USD | -9737.283% |
| Star Equity Holdings, Inc. | 45.78 Million USD | -9737.283% |
| Trinity Biotech plc | 56.83 Million USD | -7825.113% |
| T2 Biosystems, Inc. | 7.19 Million USD | -62516.433% |
| Twist Bioscience Corporation | 312.97 Million USD | -1339.097% |
| Exagen Inc. | 52.54 Million USD | -8471.211% |